Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,389 | 1,319 | 98.7% |
| Education | $261.73 | 14 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,298 | 43 | $0 (2024) |
| PFIZER INC. | $1,794 | 178 | $0 (2024) |
| ABBVIE INC. | $1,523 | 127 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,297 | 71 | $0 (2024) |
| Lilly USA, LLC | $1,226 | 87 | $0 (2024) |
| Novo Nordisk Inc | $1,014 | 82 | $0 (2024) |
| Astellas Pharma US Inc | $750.97 | 38 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $690.38 | 50 | $0 (2023) |
| Merck Sharp & Dohme LLC | $663.55 | 67 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $655.34 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,362 | 134 | PFIZER INC. ($247.29) |
| 2023 | $2,523 | 143 | AbbVie Inc. ($417.36) |
| 2022 | $2,906 | 178 | ABBVIE INC. ($400.70) |
| 2021 | $2,506 | 155 | AstraZeneca Pharmaceuticals LP ($432.96) |
| 2020 | $2,432 | 172 | AstraZeneca Pharmaceuticals LP ($311.48) |
| 2019 | $2,579 | 194 | AstraZeneca Pharmaceuticals LP ($363.94) |
| 2018 | $2,213 | 175 | PFIZER INC. ($264.34) |
| 2017 | $2,130 | 182 | Boehringer Ingelheim Pharmaceuticals, Inc. ($323.42) |
All Payment Transactions
1,333 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Oncology | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: PAIN | ||||||
| 10/28/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Hematology | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Central Nervous System | ||||||
| 10/09/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 981 | 1,998 | $178,676 | $80,233 |
| 2022 | 19 | 1,194 | 2,381 | $206,136 | $94,708 |
| 2021 | 22 | 1,478 | 2,642 | $207,212 | $95,573 |
| 2020 | 25 | 1,524 | 2,924 | $214,642 | $82,748 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 514 | $90,978 | $39,655 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 175 | 175 | $46,900 | $21,441 | 45.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 64 | 64 | $5,120 | $4,852 | 94.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 14 | $5,978 | $2,796 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 39 | $4,680 | $2,559 | 54.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 154 | 244 | $2,440 | $2,050 | 84.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $4,940 | $2,048 | 41.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 66 | $4,488 | $1,938 | 43.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 67 | 90 | $5,220 | $887.79 | 17.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 14 | $2,380 | $589.18 | 24.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 80 | 636 | $1,908 | $497.32 | 26.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 22 | 29 | $957.00 | $429.50 | 44.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 33 | 40 | $1,600 | $220.96 | 13.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 19 | $513.00 | $180.88 | 35.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 41 | $574.00 | $88.69 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 571 | $101,067 | $46,963 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 198 | 198 | $53,064 | $25,173 | 47.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 20 | 20 | $7,455 | $5,573 | 74.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 68 | $5,720 | $4,579 | 80.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 16 | $6,832 | $3,467 | 50.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 67 | 69 | $4,692 | $1,931 | 41.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 84 | 178 | $4,806 | $1,684 | 35.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 72 | 110 | $6,380 | $1,039 | 16.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 21 | $3,570 | $813.95 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 149 | 205 | $2,050 | $604.65 | 29.5% |
About Mark Simon
Mark Simon is a Family Medicine healthcare provider based in Massillon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053307694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Simon has received a total of $19,651 in payments from pharmaceutical and medical device companies, with $2,362 received in 2024. These payments were reported across 1,333 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($19,389).
As a Medicare-enrolled provider, Simon has provided services to 5,177 Medicare beneficiaries, totaling 9,945 services with total Medicare billing of $353,262. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Massillon, OH
- Active Since 09/20/2005
- Last Updated 10/22/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1053307694
Products in Payments
- FARXIGA (Drug) $1,306
- JARDIANCE (Drug) $1,095
- NURTEC ODT (Drug) $805.08
- Vascepa (Drug) $647.69
- XIFAXAN (Drug) $635.97
- VRAYLAR (Drug) $540.33
- XARELTO (Drug) $499.41
- CHANTIX (Drug) $485.59
- Ozempic (Drug) $393.96
- UBRELVY (Drug) $363.52
- MOUNJARO (Drug) $342.34
- JANUVIA (Drug) $341.35
- AJOVY (Biological) $332.83
- Kerendia (Drug) $321.55
- BREZTRI (Drug) $303.68
- QULIPTA (Drug) $302.82
- ENTRESTO (Drug) $301.17
- LINZESS (Drug) $299.56
- ELIQUIS (Drug) $298.68
- VYEPTI (Biological) $293.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Massillon
Jessica Falvo Lang, M.d, M.D
Family Medicine — Payments: $14,992
Eugene Pogorelec
Family Medicine — Payments: $14,248
Dr. Saroj Kothari, Md, MD
Family Medicine — Payments: $11,597
Steven Scheufler, M.d, M.D
Family Medicine — Payments: $9,822
Megan Hershberger, Md, MD
Family Medicine — Payments: $6,950
Dr. Tracy Kotnik, M.d., F.a.a.f.p, M.D., F.A.A.F.P
Family Medicine — Payments: $3,228